Cel
Chronic pain is estimated to affect 15-20% of children with varying disabilities. Due to the paucity of clinical information and appropriate medicinal products, in clinical practice paediatric patients are often under-treated causing profound impact on their QoL.
To date, opioids, non-steroid anti-inflammatory drugs (NSAIDs), antidepressants and anticonvulsants are used to treat pain, but only few of these include a paediatric authorisation. In addition, the few available paediatric drugs have a very different authorisation profile across Europe and, when not approved in paediatrics, they are used off-label to cover the high therapeutic need, thus exposing children to unnecessary risks of dosing errors and increasing ADRs.
The GAPP Project is focused on the development of gabapentin for the treatment of paediatric chronic pain, a condition where gabapentin, as demonstrated in adults, is expected to bring great benefit to children.
To this end, a large international scientific Consortium is set up, with experienced professionals in the field of pain that will work together with a Pharmaceutical Company committed to apply for a PUMA using the project results.
Within GAPP, age-appropriate formulation will be developed and two randomised, comparator-controlled clinical trials and a bridging study will be conducted in compliance to a submitted Paediatric Investigation Plan (PIP, Summary Report Day 90 - EMEA-001310-PIP01-12) in order to investigate appropriate dosages, efficacy and safety of gabapentin in the paediatric population. Further to this, in order to ensure the safety of gabapentin in very young children, a non clinical study will be conducted to evaluate the neurotoxic potentil of the drug. At the end of the project, gabapentin can be proposed for treatment of chronic pain in children both as monotherapy and as adjuvant therapy.
Dziedzina nauki
Zaproszenie do składania wniosków
FP7-HEALTH-2013-INNOVATION-1
Zobacz inne projekty w ramach tego zaproszenia
System finansowania
CP-FP - Small or medium-scale focused research projectKoordynator
70122 Bari
Włochy
Zobacz na mapie
Uczestnicy (16)
3015 GD Rotterdam
Zobacz na mapie
35127 Padova
Zobacz na mapie
35138 Padova
Zobacz na mapie
70124 Bari
Zobacz na mapie
26900 LODI
Zobacz na mapie
Zakończenie uczestnictwa
50406 Tartu
Zobacz na mapie
20122 Milano
Zobacz na mapie
Zakończenie uczestnictwa
67100 L'Aquila
Zobacz na mapie
WC1E 6BT London
Zobacz na mapie
91054 Erlangen
Zobacz na mapie
1001 Tirana
Zobacz na mapie
75012 Paris
Zobacz na mapie
Zakończenie uczestnictwa
46015 VALENCIA
Zobacz na mapie
1018 RG Amsterdam
Zobacz na mapie
16147 Genova
Zobacz na mapie
115 27 ATHINA
Zobacz na mapie